Attogene
Attogene is a medical technology company offering rapid diagnostic tests and devices that promote advanced and accessible healthcare. Founded in 2019, the company is dedicated to improving global health outcomes with reliable, cost-efficient testing solutions. The company's core ethos lies in innovation, social responsibility, and uncompromising quality.
Attogene offers point-of-care diagnostic testing systems for antibodies and antigens such as the SARS-CoV-2 serological assay IgG/IgM rapid test kit -- a high accuracy, rapid sample-processing system that helps clinicians get accurate results quickly, reducing the cost of treatment and helping to reduce infectious disease spread.
Attogene's products are designed for both clinical and research settings and are used by healthcare professionals, disease surveillance teams, and international laboratories worldwide. They provide rapid results, accuracy and flexibility, and an affordable price point. Their systems and products offer customers the opportunity to own, control, and manage medical data in real-time without needing an expensive, dedicated IT infrastructure.